Montanova Capital LLC Has $5.41 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Montanova Capital LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.4% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 13,600 shares of the medical equipment provider’s stock after acquiring an additional 2,300 shares during the quarter. Montanova Capital LLC’s holdings in Intuitive Surgical were worth $5,408,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of ISRG. Norges Bank acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $2,856,987,000. Bank of New York Mellon Corp bought a new stake in Intuitive Surgical during the second quarter worth about $1,335,753,000. J. Stern & Co. LLP grew its stake in Intuitive Surgical by 18,504.6% during the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock worth $1,204,788,000 after buying an additional 2,115,814 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of Intuitive Surgical by 1,043.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock valued at $760,124,000 after buying an additional 1,224,734 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in shares of Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after acquiring an additional 1,027,475 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 1.1%

Shares of ISRG stock opened at $376.86 on Tuesday. The firm has a market capitalization of $133.14 billion, a P/E ratio of 43.17, a P/E/G ratio of 2.69 and a beta of 1.47. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The stock’s fifty day simple moving average is $384.07 and its 200 day simple moving average is $431.50.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same period last year, the company earned $1.81 earnings per share. The business’s quarterly revenue was up 18.4% on a year-over-year basis. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the executive vice president owned 5,320 shares of the company’s stock, valued at $2,016,280. This represents a 6.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the transaction, the director owned 1,245,679 shares of the company’s stock, valued at approximately $498,271,600. This trade represents a 0.80% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 11,658 shares of company stock worth $4,649,835. 0.60% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Royal Bank Of Canada decreased their price target on Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a research note on Monday, July 13th. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, August 15th. Truist Financial decreased their target price on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research report on Thursday, July 16th. Citigroup dropped their target price on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a report on Friday, July 17th. Finally, BTIG Research reduced their price target on shares of Intuitive Surgical from $512.00 to $469.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $508.68.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.